Barts Cancer Institute (Queen Mary University of London)

📢 Registration is now open for our Scientific Basis of Urology Course. Join us for a four-day executive course taught by distinguished expert faculty, including key opinion leaders in their fields. We will explore the basic science of benign and malignant urological conditions. 🔗Find out more and register: https://lnkd.in/eZafXWdU 📆 Monday 9th – Thursday 12th December 2024 📍 In person in London, UK, or online. Please share with colleagues in your network who may be interested. This course is CPD accredited by THE BRITISH ASSOCIATION OF UROLOGICAL SURGEONS LIMITED and is ideal preparation for FRCS(Urol), FEBU and other postgraduate exams. #urology #cpd #surgery #postgraduate #executivecourse #studywithus

Dr. Eimear Eileen Teehan MBBS(Hons) MSc (Distinction) 🎓 I am pleased to share my successful completion of six years at Barts and The London School of Medicine and Dentistry culminating in the achievement of my Medical degree and a Masters of Science (MSc) in Laparoscopic Surgery and Surgical Skills (Distinction) at Barts Cancer Institute (Queen Mary University of London). I am incredibly grateful for the profound level of unwavering support from my family, friends and mentors throughout the six-year journey whose encouragement and guidance have played a pivotal role in my success. Celebrating this achievement with family and friends last week at St Paul's Cathedral was incredibly special and a day I will cherish forever. I am looking forward to beginning the next phase of my career as a Foundation Year 1 Doctor at Worcestershire Acute Hospitals NHS Trust in the coming weeks, and applying my practical knowledge and skills under the guidance of experienced professionals. I am incredibly excited to begin this new phase, and look forward to working together with colleagues to deliver quality patient care. Congratulations to the class of 2024, we did it!

This summer, we are connecting 16–18-year-olds with their future careers through work experience and business insight days. Giving young Londoners the skills they need to springboard themselves into employment. Last week we connected students who are passionate about science, medicine, and research, with UCL Cancer Institute and Barts Cancer Institute (Queen Mary University of London) for in-person laboratory work experience. The students worked alongside biomedical PhD students to conduct their own experiments, took a bioinformatics master class and learned cutting-edge research techniques.     These are the type of opportunities available to young people through our employability programme Access Aspiration. We work with state schools in under-resourced areas at a time when students are making crucial decisions about their futures. We give them the connections and information to open doors and get experience in careers they previously thought were unattainable. Find out more about Employability and Skills at the Mayor’s Fund for London 👇 :  https://bit.ly/4fcY0zg

💡 We're looking for a talented Bioinformatician to join our Bioinformatics Core Facility team. This role plays an integral part in cutting-edge research across the BCI. 👉 https://lnkd.in/en-Xqi9J 📆 9th August 2024 👥 Jun Wang   #bioinformatics #canceresearch

We recently held our postgraduate day – an event celebrating all the amazing work done by our research students. The day was organised by our PhD forum and featured talks, posters, and a three-minute thesis competition. Students, PIs and patient representatives voted for the best presentations. Congratulations to our winners (left to right in the second photo): ⭐ Lakshmi Rajput won best final year student presentation, as voted by students ⭐ Christos Ermogenous won best three-minute thesis presentation, as voted by students ⭐ Sophie James won best final year student presentation, as voted by PIs ⭐ Emilia Peleva won best poster presentation, as voted by students ⭐ Shoshana Burke won best poster presentation, as voted by PIs ⭐ Robert Dryden won best three-minute thesis presentation, as judged by our patient and public involvement advisory group #cancerresearch #phdstudent #gradstudent

I felt very privileged to be able to help out with the STARS programme here at Barts earlier this week. Having taken part in a similar programme at the same age as these Year 12 students and being the first in my family to go to university I know first-hand just how important and influential experiences like this can be. Seeing the enthusiasm and engagement of the students for lab work was wonderful. Hopefully, by working alongside these brilliant students and sharing stories of my journey into scientific research, these young scientists will have the confidence and the experiences they need to start their own stories post A-Level. 😊🥼

I had an absolutely lovely time teaching these A-level students! They were fantastic in the lab and it was such a rewarding experience for everyone involved. Thanks #STARS2024 and Professor John F Marshall for letting me be a part of the programme.

🌍 Join us in congratulating Professor Richard Grose who has been appointed the new Director of Queen Mary's Global Policy Institute. The Global Policy Institute aims to ensure Queen Mary's dedication to inclusion, diversity, and positive social change results in meaningful improvements to policy worldwide. The institute brings together researchers from across faculties and disciplines and applies their world-class research to tackle crucial policy issues in areas such as global health, technology, housing, and human mobility.

Meet Ryan, a student on our MSc Cancer Genomics & Data Science course. He takes us along for a typical day of studying, meeting friends and exploring at the Barts Cancer Institute, Queen Mary University of London. 🎓 Find out more about studying with us: https://lnkd.in/e-ZVXwXP #cancerresearch #studyinlondon #studyuk #postgraduatestudy

“Our early tests show we can reduce the tumour burden and extend survival.” Meet Prof Kairbaan Hodivala-Dilke, the lead scientist behind two new #innovations from Barts Cancer Institute (Queen Mary University of London) that we’re working on at QMI: A new way to treat lung cancer, and a new use for an anti-cancer agent to treat heart failure. We interviewed Kairbaan about her innovations: - Why are lung cancer and heart failure so difficult to treat? “Most lung cancer patients already have advanced stage cancer when diagnosed. These advanced cancers are inoperable and respond poorly to anti-cancer treatments.” “It’s one of the reasons why lung cancer is the leading cause of cancer deaths worldwide.” “Meanwhile heart failure affects 26 million people worldwide, with a 5-year mortality rate of 50%. There is no existing therapy to prevent disease progression for patients at risk.” “On top of this, indefinitely administrating current drugs increases the risk of side effects whilst offering no long-term benefit.” - Tell us about your innovations… “Both innovations use an αvβ3- and/or αvβ5-integrin targeting agent.” “Our new method for treating lung cancer improves the efficacy of immunotherapy and chemotherapy – which currently work for less than a third of lung cancer patients and add barely a year of life expectancy.” “The treatment works by co-administering an αvβ3- and/or αvβ5-integrin targeting agent alongside the immunotherapy/chemotherapy. Our early tests show we can reduce the tumour burden, extend survival, and allow for lower doses of immunotherapy/chemotherapy – thereby reducing side effects.” “For heart failure, we found that giving a low dose of αvβ3- and/or αvβ5-integrin targeting agent to the patient promotes normal cardiac angiogenesis, endothelial cell activation and cardiomyocyte function.” “We expect this will also be useful for other conditions involving malfunctioning vasculature.” QMI are looking for a partner to help develop these innovations further and bring them to patients. Speak with Mark Gurden to learn more.